Results 101 to 110 of about 467 (113)

Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase

open access: yesHuman Genetics, 2005
Molybdenum cofactor deficiency (MIM#252150) is a severe autosomal- recessive disorder with a devastating outcome. The cofactor is the product of a complex biosynthetic pathway involving four different genes (MOCS1, MOCS2, MOCS3 and GEPH).
Silke Leimkühler   +2 more
exaly   +3 more sources

Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH†

open access: yesHuman Mutation, 2003
Molybdenum cofactor deficiency in humans results in the loss of the activity of molybdoenzymes sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase.
Jean L Johnson
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Proteins Structure Models in the Evaluation of Novel Variant (C.472_477del) in the MOCS2 Gene

Diagnostics, 2020
Aleksandra Jezela-Stanek   +2 more
exaly  

The Clinical and Molecular Characteristics of Molybdenum Cofactor Deficiency Due to MOCS2 Mutations

Pediatric Neurology, 2019
Özgür Öztekin   +2 more
exaly  

Home - About - Disclaimer - Privacy